Furthermore, combined treatment with PQR309 and gemcitabine reduced p-STAT3, HSP60, p-GSK-3β protein levels in the xenograft tumor tissues, according to western blotting analysis (Fig. 5L and Supplementary Fig. S2Y, Z). This evidence concerns the gene STAT3 and neoplasm.